Bifeprunox
Title: Bifeprunox
CAS Registry Number: 350992-10-8
CAS Name: 7-[4-([1,1ยข-Biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone
Molecular Formula: C24H23N3O2
Molecular Weight: 385.46
Percent Composition: C 74.78%, H 6.01%, N 10.90%, O 8.30%
Literature References: Exhibits partial agonist activity at dopamine D2 and serotonin 5-HT1A receptors. Prepn: R. W. Feenstra et al., WO 9736893; eidem, US 6225312 (1997, 2001 both to Duphar); and receptor binding studies: idem et al., Bioorg. Med. Chem. Lett. 11, 2345 (2001). Analysis of binding affinity vs in vitro efficacy: A. Newman-Tancredi et al., Int. J. Neuropsychopharmacol. 8, 341 (2005). Review of development: W. Wolf, Curr. Opin. Invest. Drugs 4, 72-76 (2003).
 
Derivative Type: Methanesulfonate
CAS Registry Number: 350992-13-1
Additional Names: Bifeprunox mesylate
Manufacturers' Codes: DU-127090
Molecular Formula: C24H23N3O2.CH4O3S
Molecular Weight: 481.56
Percent Composition: C 62.35%, H 5.65%, N 8.73%, O 16.61%, S 6.66%
 
Therap-Cat: Antipsychotic.
Keywords: Antipsychotic; Dopamine-Serotonin System Stabilizer.

Others monographs:
Diphenyl SulfoneAldicarbRacemethorphanHexobendine
HematoporphyrinGuanoxabenzMethyleugenolEthinyl Estradiol
ThermorubinLaidlomycinAdefovirAprotinin
Thioglycolic AcidAcetanilideα-Hydroxybenzylphosphinic AcidStreptolydigin
©2016 DrugLead US FDA&EMEA